In the United Kingdom (U.K.) between 2003 and 2018, prescriptions for anti-anxiety medications (excluding benzodiazepines) nearly doubled among people under age 35. The prevalence of anti-anxiety prescriptions increased from 24.9 per 1,000 person-years-at-risk (PYAR) to 43.6 per 1,000 PYAR. The highest increase in prescriptions for anti-anxiety medication was 28% among people ages 25 to 44. During the same period, the prevalence of antidepressant prescriptions also nearly doubled, from 19.8 per 1,000 PYAR to 37.0 per 1,000 PYAR. Among those ages 25 to 54, the number . . .